Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
84 results about "Drug identification" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Medication delivery and monitoring system and methods
InactiveUSRE38189E1Low costLimited accessMedical devicesPressure infusionOperational systemDrugs preparations
A medication delivery and monitoring system and methods whereby drugs are safely delivered to a patient, monitored in real-time during delivery and crucial events are recorded during delivery to provide real-time, on-line information and detail for an audit trail. A novel safety label cradle unit is disclosed. Safety label cradles (SLC's) are provided in a plurality of sizes to match varying sizes of syringes which are disposed on a cradle of the SLC to provide a constant needle height on the SLC unit independent of syringe volume (barrel diameter). A selected SLC is securely affixed to a syringe by an adhesively backed label wrapping. The label is preprinted to provide drug identification indicia and drug preparation information. The information is automatically read into the system from the label. A novel delivery station of the system monitors drug delivery as a plunger of the syringe is pushed to deliver a drug to a patient. A smart tray in cooperation with a slider portion of the SLC is used to selectively deliver drugs to a port in the IV set. The smart tray comprises a first portion for carrying SLC units, an attachable second portion having a control panel for operating the system and a cover for lockably affixing the SLC units to the tray.
Owner:IBM CORP
Prescription management system
InactiveUS7072840B1Easy to solveQuality improvementMedical data miningFinanceSoftware systemDrug identification
A prescription creation software system implemented on a computer is provided. The prescription creation software system includes a prescription creation screen display to allow the data capture of information including, patient-identifying data, prescribed drug identification data and drug quantification data. The prescription creation software system additionally provides a prescriber with drug formulary information identifying at least one drug as a patient's drug formulary preference, prior to completion of the prescription.
Owner:CYBEAR
Smart adapter for infusion devices
ActiveUS20160030683A1Improve safety and efficacyInfusion syringesMicroneedlesPen InjectorDrug administration
Smart sensors are employed to determine one or more of drug identification, dose, flow rate, concentration, agglomeration, and degradation and / or other characteristics of drug administration that can be detected via sensing technology. A smart sensor(s) can be coupled to or retrofitted onto injection pen injectors and / or drug delivery cartridges and / or infusion sets or cannulae, enabling infusion sets, pen injector systems or drug delivery cartridges to improve tracking of drug self-administration and stop medication errors that occur primarily through self or automated injection (e.g., due to incorrect or incomplete dosing, excessive dose or rate, incorrect drug, or drug degradation).
Owner:BECTON DICKINSON & CO
System and method for dispensing, sorting and delivering prescription and non-prescription medications through the post office
ActiveUS20060122729A1Controlling coin-freed apparatusDigital data processing detailsDispensaryNon prescription
Owner:ESCHER GROUP
Injected drug identification and fail-safe system
The present invention is a system and method of pre-delivery drug identification. The system and method is implemented where drugs are being administered, such as in a hospital or clinic, and identifies the drug being administered to the patient before the drug reaches the patient. The system and method may utilize a sensor used for other physiologic monitoring to identify the drug. After identification, the system and method is configured to cross-reference the identified drug with the patient's prescription and allergy information, and to prevent delivery to the patient, if necessary. The system and method also utilizes data collected from the patient with a physiological monitor or a ventilator sensor to further determine whether the drug is appropriate for the patient. The method and system may also include an override system for medical personnel. The method described may be carried out by a software application.
Owner:GENERAL ELECTRIC CO
System and Method of Drug Identification Through Radio Frequency Identification (RFID)
The present invention is a system and method of drug identification through radio frequency identification “RFID.” The system and method is implemented where drugs are being administered, such as in a hospital or clinic, and identifies the drug being administered to the patient through the use of RFID tags and short and long range transceivers before the drug reaches the patient. After identification, the system and method is configured to cross reference the identified drug with the patient's prescription and allergy information, and to prevent delivery to the patient, if necessary.
Owner:GENERAL ELECTRIC CO
Injected drug identification and fail-safe system
ActiveUS20060287887A1Prevented being administeredData processing applicationsDrug and medicationsAllergyInjected drug
The present invention is a system and method of pre-delivery drug identification. The system and method is implemented where drugs are being administered, such as in a hospital or clinic, and identifies the drug being administered to the patient before the drug reaches the patient. The system and method may utilize a sensor used for other physiologic monitoring to identify the drug. After identification, the system and method is configured to cross-reference the identified drug with the patient's prescription and allergy information, and to prevent delivery to the patient, if necessary. The system and method also utilizes data collected from the patient with a physiological monitor or a ventilator sensor to further determine whether the drug is appropriate for the patient. The method and system may also include an override system for medical personnel. The method described may be carried out by a software application.
Owner:GENERAL ELECTRIC CO
Drug Identification and Treatment Method
The invention relates to methods to identify compounds that can treat autoimmune conditions and treat specified clinical disorders such as multiple sclerosis, ulcerative colitis or arthritis. Compounds include 17α-ethynylandrost-5-ene-3β,15β,7α,17β-tetrol, 4α-acetoxy-17α-ethynylandrost-5-ene-3β,7β,17β-triol, 17α-ethynylandrost-5-ene-3β,4β,7α,17β-tetrol, 17α-ethynylandrost-5-ene-3α,4β,7α,17β-tetrol and 17α-ethynylandrost-5-ene-3α,4β,17β-triol-7-one.
Owner:NEURMEDIX +2
Drug Identification and Treatment Method
ActiveUS20080153797A1Organic active ingredientsCompound screeningAutoimmune conditionUlcerative colitis
The invention relates to methods to identify compounds that can treat autoimmune conditions and treat specified clinical disorders such as multiple sclerosis, ulcerative colitis or arthritis. Compounds include 17α-ethynylandrost-5-ene-3β,11β,7α,17β-tetrol, 4α-acetoxy-17α-ethynylandrost-5-ene-3β,7β,17β-triol, 17α-ethynylandrost-5-ene-3β,4β,7α,17β-tetrol, 17α-ethynylandrost-5-ene-3α,4β,7α,17β-tetrol and 17α-ethynylandrost-5-ene-3α,4β,17β-triol-7-one.
Owner:BIOVIE INC
Drug dispense, identification, labeling and the system of inspection
InactiveUS20080128482A1Effectively control qualityEffectively control conservationStampsRecord carriers used with machinesMedicineDrug identification
This system of identification and labeling is set on the container or package of drugs and contains drug identification units for the identification of the drug name, including identification units of manufacturing batch number and time. The identification unit of manufacturing batch number is used for the identification of the batch number of the drug while the time identification unit for the identification of the expiry date of the drug, quickly making the consumers understanding the manufacturing batch number and the expiry date of the drug through reading the identification labels so as to effectively control the quality and conservation of drugs.
Owner:KO PHARML
Pre-delivery drug identification system
InactiveUS20060287884A1Block deliveryData processing applicationsDrug and medicationsAllergyDrug product
The present invention is a system and method of pre-delivery drug identification. The system and method is implemented where drugs are being administered, such as in a hospital or clinic, and identifies the drug being administered to the patient before the drug reaches the patient. After identification, the system and method is configured to cross-reference the identified drug with the patient's prescription and allergy information, and to prevent delivery to the patient, if necessary.
Owner:GENERAL ELECTRIC CO
Pharmaceutical distribution device
InactiveUS20050150809A1Small article dispensingOral administration deviceDrug productDrug identification
A method of providing items required for a complex drug regimen. In a preferred embodiment the method includes the steps of disposing a plurality of different drugs in corresponding drug compartments within a container; and providing drug identification information visually associated with each drug compartment containing a drug. The invention also includes a kit for a complex drug regimen. In a preferred embodiment the kit includes a kit container including a plurality of drug compartments, each drug compartment adapted to contain a drug; a plurality of different drugs disposed in the drug compartments; and drug identification information visually associated with each drug compartment containing a drug.
Owner:MEDSTEP HEALTH SERVICES
Tunable diode laser system for photodynamic therapy
InactiveUS6421361B1Good choiceLow costPhotodynamic therapyOptical resonator shape and constructionFiberConfocal
A tunable medical laser diode system for activating PhotoDynamic Therapy (PDT) compounds is disclosed. A tunable medical laser diode system for activating PhotoDynamic Therapy (PDT) compounds and other moderate or low energy multiple wavelength applications is disclosed. Interchangeable diode laser cartridges are used. Each cartridge contains a diode laser, which consists of at least one diode or diode array or some combination thereof. Typically, each diode laser cartridge is tuned to a different wavelength. Multiple cartridges, however may be tuned to the same wavelength for some applications One or more cartridges are attached to the system base unit simultaneously. The cartridges may be powered in series or in tandem for different applications. Selectively powering these cartridges causes light to be emitted at a certain wavelength or wavelengths. Selection of cartridges is facilitated by a drug identification scanner which scans drug activation wavelength information into the system. The wavelength can then be changed by selecting different cartridge(s) with diodes operating at other wavelengths. Applicator fiber parameters are recognized by the system as are power output and energy density. Modifications of input power are made accordingly. On a finer scale, tuning can be accomplished using a Master Oscillator Power Amplifier (MOPA). Still Finer tuning can be done by adjustment of system operating temperature. The ability to vary output wavelengths allows for multiple PDT compounds to be activated by one laser system. Other medical applications, such as aiding coagulation, may also be performed with diode lasers using the present invention, while retaining the inherent advantages of diode lasers, i.e., simplicity, low cost, and ease of maintenance.
Owner:CERAMOPTEC IND INC
Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications
InactiveUS20050119215A1Useful in treatmentSenses disorderPeptide/protein ingredientsGenomicsNucleotide
Nucleotide sequences and the corresponding polypeptide sequences implicated in the regulation of angiogenesis are identified. The nucleotide and polypeptide sequences, or pharmaceutical compositions made from such sequences, can be used in the clinical study of the angiogenesis process, the prognosis, diagnosis and treatment of pathologies linked to angiogenesis, and in the implementation of pharmacological, pharmacogenomic and drug identification trials.
Owner:GENE SIGNAL INT
A drug recognition method based on biomedical knowledge map reasoning
ActiveCN109325131ADiscovery is not limitedAuxiliary adverse reaction predictionDrug and medicationsNeural learning methodsData setBiomedical knowledge
A drug recognition method based on biomedical knowledge map reasoning comprises the following steps of S1, downloading the biomedical text data; S2 constructing a biomedical knowledge map; S3 constructing a drugs-target-disease relationship data set; S4 using a graph embedding method to learn graph representation; 5 training a drug discovery model based on a long-short memory neural network; S6 performing a drug identification step by using the trained model. The method of the invention is applicable to searching for potential therapeutic drugs for diseases, and is not limited to diseases andtypes of drugs, and has great significance to discover drugs that can be used to treat diseases from the literature.
Owner:DALIAN UNIV OF TECH
Drug identification system based on deep learning and identification method thereof
InactiveCN107545150AAvoid instabilityCharacter and pattern recognitionSpecial data processing applicationsTest sampleDrug identification
The present invention is a drug recognition system and its recognition method based on deep learning, including: 1. Preprocessing of drug image training samples, test samples, and target images. Including obtaining grayscale image, edge detection and frame processing. 2. Construct a model unit for establishing a drug recognition model based on deep learning. Including setting the initial parameters of each network layer and classifier of CNN, and inputting the above preprocessed image into CNN to obtain the features we need. 3. The identification unit is used to input the drug with identification, and then the above-mentioned established drug identification model based on deep learning obtains the convolution features of the image in the deep learning model, and cascades the obtained convolution features into the input The classifier finally outputs the recognition result. 4. Identify the hardware part of the system. It has a more accurate recognition rate and speed in various complex backgrounds and drug information, which can better reduce the error rate in drug application and the subsequent individual drug safety application platform.
Owner:张晨
Drug information management method, device and system
InactiveCN107330284ARealize full traceabilityCustomer relationshipSpecial data processing applicationsFull life cycleMedical emergency
The invention provides a drug information management method, a device and a system, wherein the method is executed by a server; the server is connected with a supply chain client, a hospital client and a patient client; the method includes steps of receiving an identification code and stock information of a drug uploaded by the supply chain client, wherein the stock information comprises stock pharmacy and stock time of the drug; receiving the drug prescription record uploaded by the hospital client, wherein the prescription record comprises disease type, doctor for providing the prescription, and the drug receiving record; receiving the drug taking record and the drug effect feedback information uploaded by the patient client; according to the drug identification code, binding and storing the stock information, prescription record, drug taking record and drug effect feedback information of the drug, and generating a full life cycle management report of the drug. The drug information management method, the device and the system can record the full-process data of the drug from production, sales to the drug feedback of a patient; a user can comprehensively master related information of the drug, thus the full-process traceability of the drug information is realized.
Owner:SHANGHAI VIEW VALLEY TECH
Method for quickly screening pesticides, drugs and converting products in waste water at same time
ActiveCN107884507AComprehensive screeningShort analysis timeComponent separationDrug DatabasesWastewater
The invention discloses a method of quickly screening pesticides, drugs and converting products in waste water at the same time, belonging to the field of analytical chemistry. The method comprises the following steps: (a) carrying out analytic detection, namely analytically detecting a sample; (b) carrying out pesticide and drug identification, namely screening by adopting pesticide and drug database software to identify whether pesticides and drugs exist or not; and (c) carrying out identifying-non-targeted screening of the converting products, namely predicting the converting products of identified pesticides and drugs in the step (b) through software, carrying out secondary spectrogram analysis and compound screening on an index compound of pesticides and drugs to predict diagnostic ions, and analyzing and identifying the converting products by extracting corresponding chromatographic peaks on the compound comprising the diagnostic ions. According to the method, pesticides, drugs and converting products in waste water can be screened at the same time, and the screening speed is high, the range is wide and the accuracy is high.
Owner:NANJING UNIV
Method for discovering potential drugs
InactiveUS20110287953A1Easy and fast processingTremendous effortLibrary screeningSystems biologyMedicineTreatment strategy
The preset invention relates to a process for discovering potential treatment strategy for a given disease, providing a niche for PPI network construction, target prioritization, and potential drug identification for a given disease, particular a cancer, based on the interaction between prioritized NPC targets (e.g. cliques and bottleneck genes) and drugs.
Owner:HUANG CHI YING +2
Drug cabinet intelligent positioning management method and system
ActiveCN109472297APrevent missellingImprove management efficiencyImage enhancementGeometric image transformationImage detectionManagement efficiency
The invention relates to a medicine cabinet intelligent positioning management method and a medicine cabinet intelligent positioning management system in the technical field of medicine retail, comprising the following steps: S1, establishing a medicine identification model and a medicine comparison model; S2, obtaining an image to be identified of the medicine in demand; 3, extract that pre-shipment drug information; 4, position correction of that image capture device; S5. Drug identification. The invention uses the image detection technology to match the expected medicine of the customer with the medicine to be shipped to prevent the wrong sale of the medicine and improve the safety of the medicine. At that same time, the medicine information in the medicine cabinet can be update in realtime, the medicine management efficiency in the medicine cabinet can be improved, and the management cost can be reduce.
Owner:陕西鑫泉通道网络科技有限公司
Reference price index for pharmaceutical products
ActiveUS20160027136A1Improve efficiencyAccurately track true market availabilityFinanceDrug and medicationsPaymentPharmacy
A pharmacy care manager (PCM) uses a reference price for a given drug that reflects the actual cost and availability of the drug in the market. The PCM determines a reference price index (RPI) using drug pricing and availability data from drug manufacturers, wholesalers, pharmacies, and the like, updated on a daily basis. Drug identification data obtained from industry publishers allow pharmaceutical products from different sources to be cross referenced. The PCM then uses the RPI as the basis for the reference price, thereby removing any arbitrariness or inconsistency in the reference price. The reference price may then be applied to pay pharmacy claims and request reimbursements from plan clients. Such an arrangement reduces or eliminates any differences between payment of claims and reimbursement.
Owner:VENTEGRA
Quality control method of tables for treating asthma
ActiveCN101361869AImprove QA stepsControl the quality of finished productsComponent separationRespiratory disorderMedicineQuality control
The invention discloses a quality control method for Xiaochuanning Pian (a tablet for treating asthma), to which drug identification and content determination are added. The method can identify the active compositions of Chinese ephedra, fructus schisandrae chinensis and radix polygalae and determine the content of Chinese ephedra to improve the exclusiveness and effectiveness of the quality control, thus being beneficial for the effective quality control of the finished Xiaochuanning Pian.
Owner:GUANGZHOU BAIYUNSHAN ZHONGYI PHARMA COMPANY
A method and a system for supervising online drug sales based on a database
InactiveCN109299958AEnsure qualified operationAchieve traceabilityBuying/selling/leasing transactionsDrugs salesDrug Databases
The invention discloses a method and a system for supervising online drug sales based on a database. The method comprises the following steps: obtaining a registration application of an online pharmacy and verifying the registration application; Successful registration of online pharmacies with approved registration requests; Storing the online pharmacy information with a successful registration mark into a pharmacy database; Determining at least one merchandise to be sold of an online pharmacy having a registration success mark, and setting drug identification information for each drug, and storing drug identification information and trade information for each drug in a drug database; Obtaining a trade request for the target drug; When the online pharmacy of the target drug has a successful registration mark, the drug identification information and the trading information of the target drug are verified; When the drug identification information of the target drug passes the verification and the trading status of the target drug is unsold, the target drug is sold; And change the trading status of the target drug to sold.
Owner:HUADI COMP GROUP
Drug identification method based on improved SURF algorithm
InactiveCN110738216AImprove efficiencyHigh matching recognition accuracyDrug and medicationsCharacter and pattern recognitionCosine similarityDrug identification
The invention discloses a drug identification method based on an improved SURF algorithm. The method comprises the steps that a drug bag image is acquired; constructing a Hessian matrix to generate interest points; constructing a scale space; positioning feature points; distributing main directions of the feature points; generating a feature point descriptor; carrying out initial extraction on thefeature points through an Euclidean distance, then screening the feature points through cosine similarity, if the cosine value ratio between two vectors is measured to be smaller than a set thresholdvalue, screening out the feature points, and otherwise, reserving the feature points; and finally, using template matching to complete drug auditing identification, i.e., selecting a template most similar to the detection image according to the matching number of the detected drug bag image and the template image matching points, wherein the type of the template is the type of the detection drugbag image. According to the method, the experimental environment during drug auditing and matching is comprehensively considered, the matching and recognition accuracy of drug bag features is high, and the method has good robustness and high matching speed in rotation and illumination.
Owner:NANJING UNIV OF SCI & TECH
Medicine classification method, device and equipment and storage medium
ActiveCN111738014AShorten the timeImprove efficiencySemantic analysisCharacter and pattern recognitionPharmaceutical drugEngineering
The invention discloses a drug classification method, device and equipment and a storage medium, and relates to the field of artificial intelligence technology deep learning and knowledge maps. According to the invention, the specific implementation scheme is that the method comprises the steps: obtaining drug identifiers of to-be-classified drugs; based on the drug identifier and a pre-trained drug classification model, determining a classification label of the to-be-classified drug. According to the invention, related data of drug identification is input into a pre-trained drug classification model; the classification labels are output by the medicine classification model, so the process of manually classifying the medicines is avoided, the problem that the classification labels of the multi-component compound medicines cannot be determined due to the fact that the classification labels are determined according to the medicine components in the prior art is solved, and the medicine classification efficiency and accuracy are effectively improved. The scheme can adopt a cloud service mode and is specifically applied to the aspect of medical big data.
Owner:BEIJING BAIDU NETCOM SCI & TECH CO LTD
Smart adapter for infusion devices
ActiveUS10398852B2Improve safety and efficacyMicroneedlesMedical devicesPen InjectorDrug administration
Owner:BECTON DICKINSON & CO
Drug identification and treatment method
The invention relates to methods to identify compounds that can treat autoimmune conditions and treat specified clinical disorders such as multiple sclerosis, ulcerative colitis or arthritis. Compounds include 17α-ethynylandrost-5-ene-3β,11β,7α,17β-tetrol, 4α-acetoxy-17α-ethynylandrost-5-ene-3β,7β,17β-triol, 17α-ethynylandrost-5-ene-3β,4β,7α,17β-tetrol, 17α-ethynylandrost-5-ene-3α,4β,7α,17β-tetrol and 17α-ethynylandrost-5-ene-3α,4β,17β-triol-7-one.
Owner:BIOVIE INC
Drug traceability management method and system based on block chain technology
PendingCN112184268AGuarantee authenticityRealize the digitization of all elementsDrug and medicationsDatabase distribution/replicationDrug identificationComputer science
The invention discloses a drug traceability management method and system based on a block chain technology. The method comprises the following steps of obtaining identity information of a plurality ofblock chain nodes and drug information supplied by each block chain node, associating a unique drug identification code for the drug information, and uploading the associated drug information to theblock chain node, authenticating the identity information of the currently accessed block chain node, and determining drug traceability information when the authentication is passed, according to a preset intelligent contract, constructing a drug circulation transaction between the authenticated block chain nodes, and updating the drug traceability state recorded by the block chain nodes, and in response to a query request for the drug traceability information, pushing the obtained query result to the access terminal. According to the drug traceability management method based on the block chain technology, what is guaranteed is that drug data cannot be tampered and are not prone to leakage, the full life cycle of production, circulation and detection of drugs is supervised, the authenticity of the data is guaranteed, and the drug traceability efficiency is improved.
Owner:GUANGZHOU FAMILY DOCTORS ONLINE INFORMATION
Cold chain tracing management method and system
The invention is suitable for the technical field of drug management and provides a cold chain tracing management method and system. The method comprises steps of updating an input mapping relation table among the drug identification number of a to-be-delivered drug, a target cold storage device and the delivery batch; timely collecting and storing a data message uploaded by each cold storage device; and when a query instruction is received, finding temperature data matching conditions from a database and transmitting the query instruction to a client. According to the invention, mobile temperature collection modules are used for temperature informatization establishment of all links of storage and delivery, safety control of internal storage, delivery and transshipment of an enterprise and real-time monitor of circulation links are achieved, and the object of tracing and recalling drugs which need refrigeration is achieved.
Owner:HUBEI JOINTOWN TECH
Drug identification system based on deep learning and implementation method thereof
InactiveCN111382622AAccurate identificationDispensing speed is fastDrug and medicationsCharacter and pattern recognitionDispensaryDrug dispensing
The invention discloses a drug identification system based on deep learning and an implementation method thereof, the drug identification system comprises a drug identification system body, and the drug identification system body comprises: a picture acquisition module used for collecting drug picture information; a detection segmentation module used for calculating the accurate position of each medicine and segmenting the medicines one by one; a controller used for receiving the feedback information, receiving the comparison information, receiving the medicine list information and sending a control instruction; an identification module used for identifying characters, texts and picture information of the medicine box and accurately identifying the types of the medicines and the number ofeach type; and a comparison module used for comparing the medicine information with the medicine list of the patient. According to the drug identification system based on deep learning and the implementation method thereof, the types and the number of drugs can be automatically and accurately identified, and the drug placing speed of a pharmacy is increased; and meanwhile, the manual operation process is replaced, and the probability of errors caused by manual drug dispensing is reduced while the labor cost is reduced.
Owner:泰芯科技(杭州)有限公司
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com